EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comorbidities in palmoplantar pustulosis: a Swedish population-based register study

Sofia Löfvendahl iD, Jenny M Norlin iD, Marcus Schmitt-Egenolf iD

British Journal of Dermatology · 2023

DOI: 10.1093/bjd/ljad134 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Dermatology, 2023. Verfasst von Sofia Löfvendahl und 2 weiteren Autor:innen. Beteiligte Einrichtung: The Swedish Institute for Health Economics (IHE), Lund. Hauptthemen laut MEDLINE: Psoriasis, Exanthema. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: AbbVie, Boehringer Ingelheim, Eli Lilly.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigated the comorbidity burden of Swedish patients with palmoplantar pustulosis (PPP) vs. the general population and patients with psoriasis vulgaris (PV). We found a significantly higher comorbidity burden in patients with PPP compared with the general population, represented by higher odds for disease across different categories (metabolic, cerebrovascular, cardiovascular, psychiatric). Although patients with PPP and PV showed similar comorbidity burdens overall, the comorbidity profiles differed significantly. Comorbidities such as type 2 diabetes and chronic obstructive pulmonary disorder, which showed both high prevalence (> 5%) in PPP and higher odds than PV, may be of particular importance for the specific comorbidity burden of PPP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisExanthemaHumansSwedenComorbidityChronic Disease

Autor:innen und Institutionen

  • The Swedish Institute for Health Economics (IHE), Lund.
  • Department of Laboratory Medicine, Lund University, Lund.
  • Department of Public Health and Clinical Medicine, Dermatology, Umeå University, Umeå, Sweden.

ORCID-Profile: Sofia Löfvendahl, Jenny M Norlin, Marcus Schmitt-Egenolf

Förderung

  • AbbVie
  • Boehringer Ingelheim
  • Eli Lilly
  • Janssen Cilag
  • Leo Pharma
  • Novartis

Zitieren

APA

Löfvendahl, S., Norlin, J. M., & Schmitt-Egenolf, M. (2023). Comorbidities in palmoplantar pustulosis: a Swedish population-based register study. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljad134

Vancouver

Löfvendahl S, Norlin JM, Schmitt-Egenolf M. Comorbidities in palmoplantar pustulosis: a Swedish population-based register study. British Journal of Dermatology. 2023. doi:10.1093/bjd/ljad134

BibTeX
@article{Lfvendahl2023,
  author = {Löfvendahl, Sofia and Norlin, Jenny M and Schmitt-Egenolf, Marcus},
  title = {Comorbidities in palmoplantar pustulosis: a Swedish population-based register study},
  journal = {British Journal of Dermatology},
  year = {2023},
  doi = {10.1093/bjd/ljad134}
}
Kostenlos starten →